Literature DB >> 11438068

Herpes simplex virus dermatitis in patients using latanoprost.

J Morales1, Z M Shihab, S M Brown, M R Hodges.   

Abstract

PURPOSE: To describe the possible association of latanoprost with herpetic dermatitis of the periocular skin.
METHOD: Interventional case reports. A 79-year-old woman with open-angle glaucoma developed a vesicular dermatitis of the left lower eyelid 14 months after starting latanoprost therapy. An 84-year-old man with pigmentary glaucoma developed a vesicular dermatitis of the right upper lid after 2 months of treatment with latanoprost and 8 days of treatment with tobramycin/dexamethasone for presumed bacterial conjunctivitis. In both cases, the dermatitis was characteristic of a herpetic infection.
RESULTS: Latanoprost was discontinued in both cases. The woman was treated with vidarabine 3% ointment, and the man was not treated with antiviral agents. In both patients, the dermatitis healed uneventfully. The lesions of the man were cultured, and a biopsy was performed; herpes simplex virus type 1 was recovered from the culture and confirmed by immunofluorescence testing.
CONCLUSION: Latanoprost, which has been associated with reactivation of herpetic keratitis, may also cause reactivation of herpetic dermatitis of the periocular skin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438068     DOI: 10.1016/s0002-9394(01)01012-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

Review 2.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

3.  Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence.

Authors:  Bonnie He; Hamid Tavakoli; Mahyar Etminan; Shayan Shokoohi; Alfonso Iovieno; Sonia N Yeung
Journal:  Int Ophthalmol       Date:  2022-10-12       Impact factor: 2.029

4.  Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

Authors:  Nikos N Markomichelakis; Agori Kostakou; Ioannis Halkiadakis; Sonia Chalkidou; Dimitrios Papakonstantinou; Gerasimos Georgopoulos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-28       Impact factor: 3.117

5.  First-line treatment for elevated intraocular pressure (IOP) associated with open-angle glaucoma or ocular hypertension: focus on bimatoprost.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2007-09

6.  Bimatoprost in the treatment of eyelash hypotrichosis.

Authors:  Simon K Law
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 7.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

Review 8.  Latanoprost : an update of its use in glaucoma and ocular hypertension.

Authors:  Caroline M Perry; Jane K McGavin; Christine R Culy; Tim Ibbotson
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  The management of glaucoma and intraocular hypertension: current approaches and recent advances.

Authors:  Robert J Noecker
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

10.  Reactivation of herpes simplex viral keratitis following the botulinum toxin injection.

Authors:  Muralidhar Ramappa; Peter Y Jiya; Sunita Chaurasia; Milind Naik; Savitri Sharma
Journal:  Indian J Ophthalmol       Date:  2018-02       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.